Delivery Order SPE2DB22D1106-SPE2DB25FFHD9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, valued at $1,283.69. This non-set-aside, competitively awarded contract operates under a firm fixed-price arrangement with an ultimate completion date of August 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- The Defense Logistics Agency awarded a $1,480.32 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with completion scheduled for September 9, 2025. The contract employs firm fixed pricing under a non-competitive, non-set-aside delivery order structure. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with a ceiling value of $1,743.23. This contract is structured as a firm fixed price delivery order with an ultimate completion date of June 23, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clindamycin 600 mg/50 ml in D5W solution with a ceiling value of $1,210.80 and an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin Phosphate 1% Lotion in 60ml quantities, with a ceiling value of $3,766.03. This competitive award, issued with firm fixed pricing and no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.16 for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution on August 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.80 to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ml quantities. This contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin PH 1% Solution in 60ML quantities, with a contract ceiling value of $1,179.36. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHD9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Clindamycin (pediatric formulation) 75 mg/5 ml in 100 ml quantities, with a ceiling value of $1,865.88. This firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized competitive procurement procedures with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The pediatric antibiotic delivery represents one of many critical medical commodities the company provides through this strategic partnership with the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/5/25 |